Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
The Portuguese Society of Rheumatology position paper on the use of biosimilars.

Acta reumatologica portuguesa

Fonseca JE, Gonçalves J, Araújo F, Cordeiro I, Teixeira F, Canhão H, da Silva JA, Garcês S, Miranda LC, Ramiro S, Roxo A, Pimentel-Santos FM, Tavares V, Neto A, Sepriano A, Malcata A, Faustino A, Silva C, Ambrósio C, Duarte C, Miguel C, Barcelos F, Santos H, Cunha I, Ramos JC, Gomes JA, Pimentão JB, Costa L, Maurício L, Silva M, Bernardes M, Bogas M, Coelho PC, Monteiro P, Aguiar R, André R, Leitão R, Pimenta S, Meirinhos T, Fernandes S, Las V, Castelão W.
PMID: 24811463
Acta Reumatol Port. 2014 Jan-Mar;39(1):60-71.

Biotechnological drugs have become a fundamental resource for the treatment of rheumatic patients. Patent expiry of some of these drugs created the opportunity for biopharmaceutical manufacturers to develop biosimilar drugs intended to be as efficacious as the originator product...

Biological therapies in children with rheumatic diseases during the COVID-19 pandemic: A single-centre experience.

International journal of clinical practice

Aydın F, Kurt T, Sezer M, Tekgöz N, Ekici Tekin Z, Kanık Yüksek S, Çelikel Acar B.
PMID: 34233400
Int J Clin Pract. 2021 Jul;75(7):e14030. doi: 10.1111/ijcp.14030.

No abstract available.

Showing 1 to 2 of 2 entries